Hepatic Oncology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.0 | Q4 | 25.2% | 0.411 | Q3 | 54.2% |
| 2024 | 1.3 | Q4 | 16.6% | 0.370 | Q3 | 52.4% |
| 2023 | 1.2 | Q4 | 15.5% | 0.155 | Q4 | 26.2% |
| 2022 | 5.0 | 70.9% | — | 4.3% | ||
| 2021 | — | 25.2% | — | — | ||
| 2020 | — | — | — | 0.0% | ||
| 2019 | — | — | 0.397 | Q3 | 60.8% | |
| 2018 | — | — | 0.920 | Q2 | 82.3% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
2045-0931
ISSN
2045-0923
country
GBcoverage
2016, 2020, 2022-2025